Polysaccharide-derived nitric oxidereleasing carbon-bound diazeniumdiolates

Details for Australian Patent Application No. 2006309212 (hide)

Owner Government of The United States of America, represented by The Secretary Department of Health and Human Services

Inventors Hrabie, Joseph A.; Keefer, Larry K.

Agent Fisher Adams Kelly

Pub. Number AU-B-2006309212

PCT Pub. Number WO2007/053292

Priority 60/731,946 31.10.05 US

Filing date 16 October 2006

Wipo publication date 10 May 2007

Acceptance publication date 15 September 2011

International Classifications

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

22 May 2008 PCT application entered the National Phase

  PCT publication WO2007/053292 Priority application(s): WO2007/053292

15 September 2011 Application Accepted

  Published as AU-B-2006309212

19 January 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006309231-Web terminal and bridge that support passing of authentication data to acquirer for payment processing

2006309205-Processing of angiogenic scaffolds for large organ regeneration